Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

GeneDx Holdings (WGS) Accumulated Depreciation & Amortization (2020 - 2025)

GeneDx Holdings (WGS) has disclosed Accumulated Depreciation & Amortization for 6 consecutive years, with $9.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 21.52% to $9.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.6 million, a 21.52% increase, with the full-year FY2025 number at $9.6 million, up 21.52% from a year prior.
  • Accumulated Depreciation & Amortization was $9.6 million for Q4 2025 at GeneDx Holdings, up from $6.8 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $50.0 million in Q4 2022 to a low of $1.7 million in Q1 2024.
  • A 5-year average of $10.3 million and a median of $6.2 million in 2022 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: skyrocketed 253.18% in 2022, then crashed 73.41% in 2023.
  • GeneDx Holdings' Accumulated Depreciation & Amortization stood at $21.8 million in 2021, then surged by 129.28% to $50.0 million in 2022, then plummeted by 60.6% to $19.7 million in 2023, then tumbled by 59.9% to $7.9 million in 2024, then increased by 21.52% to $9.6 million in 2025.
  • Per Business Quant, the three most recent readings for WGS's Accumulated Depreciation & Amortization are $9.6 million (Q4 2025), $6.8 million (Q3 2025), and $2.3 million (Q2 2025).